Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. (Q46809320)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. |
scientific article |
Statements
1 reference
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. (English)
1 reference
1 reference
Ruth E Langley
1 reference
James Carmichael
1 reference
Alison L Jones
1 reference
David A Cameron
1 reference
Wendi Qian
1 reference
Barbara Uscinska
1 reference
Mahesh Parmar
1 reference
1 November 2005
1 reference
23
1 reference
33
1 reference
8322-8330
1 reference